Brent crude reversed earlier gains to trade 1% lower at $77.25 a barrel, while the FTSE 100 pared its losses to just a 0.1% decline at 10,474, weighed down by a 7.4% slump in AstraZeneca shares after the failure of a late-stage heart disease drug trial.